PetMed Express, Inc. (NASDAQ:PETS) will be releasing its earnings data on Monday, October 23rd. Analysts expect PetMed Express to post earnings of $0.31 per share for the quarter.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Monday, July 24th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The business had revenue of $79.66 million during the quarter, compared to the consensus estimate of $77.32 million. During the same quarter in the previous year, the firm posted $0.32 EPS. The firm’s revenue was up 9.9% on a year-over-year basis. On average, analysts expect PetMed Express to post $1.42 EPS for the current fiscal year and $1.51 EPS for the next fiscal year.

Shares of PetMed Express, Inc. (NASDAQ:PETS) opened at 36.74 on Friday. The company has a market cap of $745.53 million, a P/E ratio of 28.26 and a beta of 1.03. The firm has a 50-day moving average of $35.65 and a 200-day moving average of $35.91. PetMed Express, Inc. has a 52-week low of $18.90 and a 52-week high of $50.90.

COPYRIGHT VIOLATION NOTICE: “PetMed Express, Inc. (PETS) Set to Announce Earnings on Monday” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/22/petmed-express-inc-pets-set-to-announce-earnings-on-monday.html.

A number of research analysts have issued reports on the stock. Northcoast Research upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price target on the stock in a research note on Monday, July 24th. Noble Financial restated a “hold” rating on shares of PetMed Express in a research note on Wednesday, July 26th. Craig Hallum restated a “hold” rating and set a $40.00 price target (down previously from $43.00) on shares of PetMed Express in a research note on Monday, August 21st. They noted that the move was a valuation call. Credit Suisse Group restated an “underperform” rating and set a $19.00 price target on shares of PetMed Express in a research note on Monday, October 2nd. Finally, BidaskClub lowered shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. One analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $40.00.

In other news, Director Robert C. Schweitzer sold 2,500 shares of the stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $49.18, for a total value of $122,950.00. Following the sale, the director now owns 88,834 shares in the company, valued at $4,368,856.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Bruce S. Rosenbloom sold 6,833 shares of the stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $50.18, for a total transaction of $342,879.94. Following the completion of the sale, the chief financial officer now owns 18,534 shares in the company, valued at approximately $930,036.12. The disclosure for this sale can be found here. Insiders have sold a total of 19,333 shares of company stock worth $949,730 in the last 90 days. 4.00% of the stock is currently owned by company insiders.

PetMed Express Company Profile

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Earnings History for PetMed Express (NASDAQ:PETS)

Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.